ArticleJournal of addiction medicine

The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible.

Jennifer J Carroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.